---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-058791"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:17:18.994008+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks COO Reshma Shetty transitions role; Jennifer Wipf assumes ops duties

## Summary
- Dr. Reshma Shetty steps down as COO effective Jan 1, 2026; remains President and Board member.
- She will focus on expanding autonomous lab for cell engineering service offerings.
- CEO Dr. Jason Kelly assumes principal operating officer oversight duties.
- Jennifer Wipf (ex-CCO/GM) takes on day-to-day operations, reporting to Kelly.
- Wipf brings vaccine and plant management experience from over a decade at Merck.

## SEC filing metadata
- accession: 0001628280-25-058791
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828025058791/0001628280-25-058791-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828025058791/dna-20251218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-058791
- JSON: https://secwatch.observer/filing/0001628280-25-058791.json
- Plain text: https://secwatch.observer/filing/0001628280-25-058791.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.